Analysed IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) News Sources
How Strong H1 Profits and Kimtrak Survival Data At Immunocore (IMCR) Have Changed Its Investment Story
07-08-2026
yahoo.com
Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma
14-09-2026
yahoo.com
Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes
15-10-2026
yahoo.com
Should First Type 1 Diabetes Dosing Require Action From Immunocore Stock Investors?
29-10-2026
yahoo.com
What is the current price of IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ)?
The current price of IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) is $30.49.
IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) since the previous trading day is $-0.78.
IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) since the previous trading day is -2.4944%.
What is the most recent average sentiment score for IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ)?
The most recent average sentiment score for IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ)?
The most recent sentiment for IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) is .
SEC-8K** Filing Available For IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.